Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD)

Preventing relapse of myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD) with steroids and immunosuppressants is sometimes difficult. There is no standard treatment for refractory cases. We present the case of a 17-year-old female patient with longitudinally extensive my...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Satomi Hiya, Hajime Yoshimura, Michi Kawamoto
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Elsevier 2023-06-01
Seri Bilgileri:	eNeurologicalSci
Konular:	Myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD) Adolescent Neuromyelitis optica spectrum disorder (NMOSD) Multiple sclerosis (MS) Ofatumumab
Online Erişim:	http://www.sciencedirect.com/science/article/pii/S2405650223000199
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!